Dow Up0.51% Nasdaq Up0.24%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
10.33 Down 0.02(0.19%) Nov 21, 4:00PM EST
|After Hours : 10.33 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 3,238   1,466   3,458   10,567  
Cost of Revenue -   -   -   -  
Gross Profit 3,238   1,466   3,458   10,567  
Operating Expenses
Research Development13,036  11,067  9,183  16,253  
Selling General and Administrative1,812  2,013  1,588  631  
Non Recurring -  5  73  17  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,610) (11,619) (7,386) (6,334)
Income from Continuing Operations
Total Other Income/Expenses Net4,096  (1,805)(1,509)2,147  
Earnings Before Interest And Taxes(7,514)(13,424)(8,895)(4,187)
Interest Expense1,217  1,225  1,242  1,242  
Income Before Tax(8,731)(14,649)(10,137)(5,429)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,731)(14,649)(10,137)(5,429)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,731) (14,649) (10,137) (5,429)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,731) (14,649) (10,137) (5,429)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.